Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 2Phase NA 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 2Thoracic 1

Conditions

Prostatic Neoplasms 2Inflammation 1

Interventions

Docetaxel 77Radiotherapy 73Prednisone 66Leuprolide 51Goserelin 49Gemcitabine 49Cisplatin 48bicalutamide 46enzalutamide 43Androgen Antagonists 36pembrolizumab 32Abiraterone Acetate 31Mitomycin 29acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 28Magnetic Resonance Spectroscopy 28Carboplatin 27Flutamide 25Nivolumab 24Triptorelin Pamoate 23Sunitinib 23apalutamide 22Radiation 22Doxorubicin 20darolutamide 19abiraterone 18Gonadotropin-Releasing Hormone 18cabozantinib 17atezolizumab 16Specimen Handling 16Radiosurgery 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Tea × Genitourinary × Clear all
NCT00003367 2013-06-26

Diet and PSA Levels in Patients With Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
154 enrolled
Genitourinary

Prostatic Neoplasms

NCT01367418 2012-03-19

AIMS

Örebro University, Sweden

Phase 3 Completed
26 enrolled
Genitourinary

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡